ESC 365 - Persistence with macitentan versus other endothelin receptor antagonists in patients with pulmonary arterial hypertension: experience from a real-world data repository in the USA

ESC Professional Premium Access

Persistence with macitentan versus other endothelin receptor antagonists in patients with pulmonary arterial hypertension: experience from a real-world data repository in the USA

Session: Hypertension - Treatment lifestyle and pharmacotherapy

Topic: Treatment

Speaker: Doctor S. Panjabi (San Mateo, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Sumeet Panjabi

San Mateo (United States of America)

0 follower

4 more presentations in this session

Comparison of clinical and economic burden of pulmonary arterial hypertension patients with and without connective tissue disease treated with macitentan

Speaker: Doctor C. Worden (Titusville, US)

Additional opportunities for antihypertensive therapy improvement in young patients with arterial hypertension and concomitant obesity

Speaker: Doctor K. Chernyshova (Odessa, UA)

The music therapy effectiveness in hypertensive patients with acute myocardial infarction after previous coronary artery bypass surgery; 18-year experience of the MUSIC study

Speaker: Professor P. Mitrovic (Belgrade, RS)

Angiotensin receptor blockers are equally effective in women and men; a systematic review and meta-analysis

Speaker: Mrs S. Laven (Maastricht, NL)

Access the full session

Hypertension - Treatment lifestyle and pharmacotherapy

Speakers: Doctor S. Panjabi, Doctor C. Worden, Doctor K. Chernyshova, Professor P. Mitrovic, Mrs S. Laven

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources